Nkarta, Inc.
Nkarta develops allogeneic, off-the-shelf natural killer cell therapies for autoimmune diseases.
424B3Nov 12Latest SEC filing
Nov 6Latest story
Nkarta develops allogeneic, off-the-shelf natural killer cell therapies for autoimmune diseases.